Abraham, Fruchter & Twersky, LLP Files Class Action Suit Against Inverness Medical Innovations Inc.

NEW YORK, NY--(Marketwire - April 11, 2008) - Abraham, Fruchter & Twersky, LLP filed a class action lawsuit in the United States District Court for the District of Massachusetts on behalf of purchasers of the common stock of Inverness Medical Innovations Inc. ("Inverness Medical" or the "Company") (AMEX: IMA) in the Company's secondary public offering on or about November 14, 2007 (the "Class Period").

The complaint charges the Company and certain of its officers and directors with violations of the Securities Act. Inverness Medical engages in the development, manufacture, and marketing of consumer and professional medical diagnostic products, as well as a range of vitamins and nutritional supplements worldwide.

According to the complaint, on or about November 14, 2007, the Prospectus supplement to the Registration Statement (the "Registration Statement") with respect to the Secondary Offering, which forms part of the Registration Statement, became effective and more than 12 million shares of Inverness Medical common stock were sold to the public at $61.49 per share, thereby raising more than $737 million. The complaint alleges that the Registration Statement negligently failed to disclose the significant and severe integration issues that the Company was then experiencing and which were then impacting the Company's continuing operations.

Plaintiff seeks to recover damages on behalf of all purchasers of Inverness Medical's common stock during the Class Period (the "Class"). The Plaintiff is represented by Abraham, Fruchter & Twersky, LLP which has extensive experience in securities class action cases, having been ranked among the leading class action law firms in terms of recoveries achieved by a survey of class action law firms conducted by Institutional Shareholder Services.

If you would like to discuss this action or if you have any questions concerning this notice or your rights as a potential class member or lead plaintiff, you may contact: Jack Fruchter or Arthur J. Chen of Abraham, Fruchter & Twersky, LLP at 212-279-5050, or via e-mail at jfruchter@aftlaw.com or achen@aftlaw.com, respectively. If you wish to serve as lead plaintiff, you must move the Court no later than June 8, 2008. Any member of the proposed class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain a member of the proposed class.

Contact Information: Contact: Jack Fruchter, Esq. Arthur J. Chen, Esq. Abraham, Fruchter & Twersky, LLP One Penn Plaza, Suite 2805 New York, New York 10119 Tel.: (212) 279-5050